← К результатам

J Biosci Bioeng · 2021

Genome editing by miniature CRISPR/Cas12f1 enzyme in Escherichia coli.

Journal of bioscience and bioengineering, 132(2): 120-124 PMID 34023220 DOI 10.1016/j.jbiosc.2021.04.009

Открыть в PubMed ↗ Открыть по DOI ↗

Аннотация

The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system is a valuable genome editing tool for microorganisms. However, the commonly used Cas9 nuclease derived from Streptococcus pyogenes (SpCas9) is not applicable to many industrially relevant bacteria, due to its cytotoxicity and large size (1368 amino acids [aa]). We developed an alternative genome editing system using a miniature Cas12f1 nuclease (529 aa) derived from an uncultured archaeon, Un1Cas12f1. When editing four dispensable genes in Escherichia coli MG1655 and BW25113, the CRISPR/Un1Cas12f1 system showed higher efficiency (63%-100%) than the CRISPR/SpCas9 system (50%-79%). The CRISPR/Un1Cas12f1 genome editing system is expected to be applied to the genome editing of a wide variety of bacteria.

Цитирование